Our studies suggest that the requirement for CDK4/6 kinase activity in ccRCC involves at least one CDK4/6 substrate beyond pRB, which could help explain the conspicuous absence of RB1 mutations in ccRCC. Here, RB1 is linked to nonpapillary renal cell carcinoma.